Document is current

Article History

Received: 10 March 2023

Revised: 14 July 2023

Accepted: 19 July 2023

First Online: 29 July 2023

Declarations

:

: S. F. received honoraria from Takeda, Sanofi, Janssen, Ono, Bristol-Myers Squibb. T. I. received honoraria from Ono, Takeda, Janssen, Sanofi, and Bristol-Myers Squibb, and received research funding from Takeda, Janssen, Pfizer, Bristol-Myers Squibb, and Sanofi. C. N. received honoraria from Janssen, Bristol-Myers Squibb, Novartis, Fujimoto, and Takeda. K. S. received honoraria from Ono, Bristol-Myers Squibb, Takeda, and Sanofi, and received research funding from Ono, Celgene, Abbvie, Takeda, Sanofi, Bristol-Myers Squibb, GlaxoSmithKlein, Chugai, Otsuka, and Janssen. S. I. received honoraria from Janssen, Bristol-Myers Squibb, Ono, Takeda, and Sanofi, and received research funding from Sanofi, Chugai, Ono, Takeda, Janssen, Bristol-Myers Squibb, Abbvie, Novartis, Amgen, Daiichi Sankyo, Otsuka, Celgene, Alexion and GlaxoSmithKlein. C. S. received honoraria from Sanofi, Janssen, Bristol-Myers Squibb.